mRNA |
KIN001-260 |
GDSC1000 |
pan-cancer |
AAC |
0.064 |
0.05 |
mRNA |
NVP-231 |
CTRPv2 |
pan-cancer |
AAC |
0.066 |
0.05 |
mRNA |
linifanib |
CTRPv2 |
pan-cancer |
AAC |
0.073 |
0.05 |
mRNA |
GDC-0449 |
GDSC1000 |
pan-cancer |
AAC |
0.073 |
0.05 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.059 |
0.05 |
mRNA |
Axitinib |
GDSC1000 |
pan-cancer |
AAC |
0.072 |
0.05 |
mRNA |
BRD-K86535717 |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.05 |
mRNA |
JQ-1:MK-0752 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.067 |
0.05 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.069 |
0.05 |
mRNA |
BRD-K14844214 |
CTRPv2 |
pan-cancer |
AAC |
-0.077 |
0.06 |